ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2025 Earnings Call Transcript February 27, 2026
ANI Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $1.41 EPS, expectations were $1.99.
Operator: Good day, everyone, and welcome to today’s ANI Pharmaceuticals, Inc. Fourth Quarter and Full Year 2025 Earnings Results Call. Please note, this call is being recorded. [Operator Instructions] It is now my pleasure to turn the conference over to Courtney Moverly. Please go...
